Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Envista Holdings Corp (NVST)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: NVST (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -51.41% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.10B USD | Price to earnings Ratio - | 1Y Target Price 21.33 |
Price to earnings Ratio - | 1Y Target Price 21.33 | ||
Volume (30-day avg) 2944055 | Beta 1.33 | 52 Weeks Range 15.14 - 23.00 | Updated Date 03/27/2025 |
52 Weeks Range 15.14 - 23.00 | Updated Date 03/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -6.67 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -44.56% | Operating Margin (TTM) 9.13% |
Management Effectiveness
Return on Assets (TTM) 1.64% | Return on Equity (TTM) -31.47% |
Valuation
Trailing PE - | Forward PE 17.21 | Enterprise Value 3503944214 | Price to Sales(TTM) 1.24 |
Enterprise Value 3503944214 | Price to Sales(TTM) 1.24 | ||
Enterprise Value to Revenue 1.4 | Enterprise Value to EBITDA 24.09 | Shares Outstanding 172188000 | Shares Floating 171556130 |
Shares Outstanding 172188000 | Shares Floating 171556130 | ||
Percent Insiders 0.86 | Percent Institutions 115.8 |
Analyst Ratings
Rating 3.29 | Target Price 21.33 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 10 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Envista Holdings Corp
Company Overview
History and Background
Envista Holdings Corp. was formed in 2019 when Danaher Corporation spun off its dental business. Its roots trace back to established dental companies like KaVo Kerr and Nobel Biocare, with a history of innovation in dental technologies.
Core Business Areas
- Specialty Products & Technologies: Develops, manufactures, and markets a broad range of dental implant systems, restorative materials, endodontic solutions, and orthodontics.
- Equipment & Consumables: Provides dental imaging systems, dental treatment units, infection prevention products, and other consumables used in dental practices.
Leadership and Structure
Envista is led by Amir Aghdaei (CEO). The organizational structure is segmented by its core business areas, with leadership teams focused on each segment's growth and performance.
Top Products and Market Share
Key Offerings
- Nobel Biocare Implants: A leading brand in dental implants. Market share is estimated around 20% globally in the premium implant segment. Competitors include Straumann (STMN.SW) and Dentsply Sirona (XRAY). Revenue is not broken out per product but the implant segment drives a large portion of Specialty Products sales.
- KaVo Kerr Imaging: Provides dental imaging solutions like cone beam computed tomography (CBCT) and intraoral scanners. Market share varies by region, but is a significant player in the overall dental imaging market. Competitors include Planmeca and Carestream Dental. Revenue is not broken out per product but the imaging equipment segment drives a portion of Equipment & Consumables sales.
- Ormco Braces and Aligners: Provider of orthodontic treatments, including metal braces, self-ligating brackets, and clear aligners (Spark). Market share is smaller than that of Align Tech (ALGN). Revenue is not broken out per product but the orthodontic segment drives a portion of Specialty Products sales.
Market Dynamics
Industry Overview
The dental industry is growing, driven by increasing awareness of oral health, an aging population, and advancements in dental technology. Demand for cosmetic dentistry and digital solutions is also on the rise.
Positioning
Envista is positioned as a leading provider of dental products and solutions, with a focus on innovation and digital dentistry. The company has a strong presence in both developed and emerging markets.
Total Addressable Market (TAM)
The global dental market is estimated at approximately $40-50 billion. Envista's positioning in key segments allows it to address a significant portion of this TAM, particularly in implants, orthodontics, and digital imaging.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio with established brands
- Global presence and distribution network
- Focus on innovation and digital dentistry
- Diverse product portfolio
Weaknesses
- Exposure to economic cycles affecting dental spending
- Competition from larger, more diversified players
- Dependence on key products and technologies
- Integration of acquired businesses
Opportunities
- Expanding into emerging markets
- Developing new digital solutions for dental practices
- Acquiring complementary businesses
- Increasing adoption of preventative dentistry
Threats
- Economic downturns impacting dental spending
- Increasing competition from new entrants
- Regulatory changes affecting dental products
- Technological disruptions
Competitors and Market Share
Key Competitors
- XRAY
- ALGN
- STMN.SW
Competitive Landscape
Envista's competitive advantage lies in its strong brand portfolio, global presence, and focus on digital dentistry. However, it faces competition from larger, more diversified players with greater resources.
Major Acquisitions
Carestream Dental Intraoral Scanners Business
- Year: 2024
- Acquisition Price (USD millions): 600
- Strategic Rationale: Expands Envista's position in the growing digital dentistry market.
Sonendo
- Year: 2024
- Acquisition Price (USD millions): 85
- Strategic Rationale: Expands Envista's position in the endodontic dentistry market.
Growth Trajectory and Initiatives
Historical Growth: Envista's growth has been driven by organic growth and acquisitions. The company's focus on digital dentistry and emerging markets is expected to drive future growth.
Future Projections: Future projections require access to analyst reports. Analyst estimates would need to be consulted for projections of revenue and earnings growth.
Recent Initiatives: Recent initiatives include new product launches in digital dentistry, expansion into emerging markets, and strategic acquisitions.
Summary
Envista Holdings Corp is a significant player in the dental industry with strong brands and a focus on digital dentistry. Its strengths include a global presence and diverse product portfolio. However, Envista must navigate economic cycles and competition. Recent acquisitions should help to propel continued growth in its core segments.
Similar Companies
- XRAY
- ALGN
- DHR
- BSX
Sources and Disclaimers
Data Sources:
- Envista Holdings Corp. Investor Relations
- Analyst reports
- Industry publications
- Company Press Releases
Disclaimers:
This analysis is based on publicly available information and represents an AI-based assessment. Financial data and market share figures are estimates and may vary. Investment decisions should be based on individual due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envista Holdings Corp
Exchange NYSE | Headquaters Brea, CA, United States | ||
IPO Launch date 2019-09-18 | CEO & Director Mr. Paul A. Keel | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 12300 | Website https://envistaco.com |
Full time employees 12300 | Website https://envistaco.com | ||
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.